anesthesia glp-1 Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement Aspiration risk and strategic approach
Description
Background/objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in treating type 2 diabetes and obesity, offering established metabolic and cardiovascular benefits
The trial had been scheduled to begin in June in the U.S
GLP-1 medications, known for helping with weight loss, offer surprising benefits for people with kidney disease
Nausea affects up to 25% of GLP-1 users during dose titration
Endocrinologist and weight-management specialist Dr
